These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Garbuzenko O; Barenholz Y; Priev A Chem Phys Lipids; 2005 Jun; 135(2):117-29. PubMed ID: 15921973 [TBL] [Abstract][Full Text] [Related]
6. Sterol-modified PEG lipids: alteration of the bilayer anchoring moiety has an unexpected effect on liposome circulation. Dolor A; Kierstead P; Dai Z; Szoka FC Chem Commun (Camb); 2018 Oct; 54(84):11949-11952. PubMed ID: 30288531 [TBL] [Abstract][Full Text] [Related]
7. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies. Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical study of the protein-liposome interactions: influence of liposome composition and concentration on protein binding. Foteini P; Pippa N; Naziris N; Demetzos C J Liposome Res; 2019 Dec; 29(4):313-321. PubMed ID: 29685077 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of PEGylated bolaamphiphiles with enhanced retention in liposomes. Zhang Y; Mintzer E; Uhrich KE J Colloid Interface Sci; 2016 Nov; 482():19-26. PubMed ID: 27485501 [TBL] [Abstract][Full Text] [Related]
10. The encapsulation and release of guanosine from PEGylated liposomes. Er Y; Barnes TJ; Fornasiero D; Prestidge CA J Liposome Res; 2009; 19(1):29-36. PubMed ID: 19515005 [TBL] [Abstract][Full Text] [Related]
11. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether. Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302 [TBL] [Abstract][Full Text] [Related]
12. Aggregation of polyethylene glycol polymers suppresses receptor-mediated endocytosis of PEGylated liposomes. Shen Z; Ye H; Kröger M; Li Y Nanoscale; 2018 Mar; 10(9):4545-4560. PubMed ID: 29461551 [TBL] [Abstract][Full Text] [Related]
13. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983 [TBL] [Abstract][Full Text] [Related]
14. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Carrion C; Domingo JC; de Madariaga MA Chem Phys Lipids; 2001 Nov; 113(1-2):97-110. PubMed ID: 11687230 [TBL] [Abstract][Full Text] [Related]
15. Dynamic and structural aspects of PEGylated liposomes monitored by NMR. Leal C; Rögnvaldsson S; Fossheim S; Nilssen EA; Topgaard D J Colloid Interface Sci; 2008 Sep; 325(2):485-93. PubMed ID: 18589432 [TBL] [Abstract][Full Text] [Related]
16. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes. Moghimi SM Biomaterials; 2006 Jan; 27(1):136-44. PubMed ID: 16019063 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Zalipsky S; Mullah N; Harding JA; Gittelman J; Guo L; DeFrees SA Bioconjug Chem; 1997; 8(2):111-8. PubMed ID: 9095350 [TBL] [Abstract][Full Text] [Related]
19. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Nag OK; Yadav VR; Hedrick A; Awasthi V Int J Pharm; 2013 Mar; 446(1-2):119-29. PubMed ID: 23419666 [TBL] [Abstract][Full Text] [Related]
20. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]